发明授权
- 专利标题： Controlled activation ingestible identifier
- 专利标题（中）： 受控活化可摄取标识符
-
申请号： US12447172申请日： 2007-10-25
-
公开(公告)号： US08945005B2公开(公告)日： 2015-02-03
- 发明人: Hooman Hafezi , Timothy Robertson , Olivier Colliou , Mark Zdeblick
- 申请人： Hooman Hafezi , Timothy Robertson , Olivier Colliou , Mark Zdeblick
- 申请人地址： US CA Redwood City
- 专利权人： Proteus Digital Health, Inc.
- 当前专利权人： Proteus Digital Health, Inc.
- 当前专利权人地址： US CA Redwood City
- 代理机构： K&L Gates LLP
- 国际申请： PCT/US2007/082563 WO 20071025
- 国际公布： WO2008/052136 WO 20080502
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61P43/00 ; H01M6/32 ; A61K49/00 ; H01M10/04 ; A61B5/07 ; A61B5/145 ; A61B5/1473 ; A61B5/00 ; H01M10/00 ; A61J3/00
摘要：
Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
公开/授权文献
- US20100239616A1 CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER 公开/授权日：2010-09-23
信息查询
